Исследования
Данный раздел содержит список клинических исследований, проводимых на территории Украины. Чтобы найти подходящее исследование, используйте фильтры.
Показаны исследования 1-50 из 614
| Название исследования | Состояние | |
|---|---|---|
| A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease | Активный, набор окончен |
|
| A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. | Активный, набор окончен |
|
| Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | Активный, набор окончен |
|
| Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer | Активный, набор окончен |
|
| Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ?‰? 500 and ?‰¤ 2000 mg/dL | Активный, набор окончен |
|
| EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | Активный, набор окончен |
|
| Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer | Активный, набор окончен |
|
| Study to Assess the Safety of CDP870 for up to 84 Months Following Reintroduction of Treatment | Активный, набор окончен |
|
| Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL) | Активный, набор окончен |
|
| ABR-217620 With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma | Активный, набор окончен |
|
| Evaluation of Tiotropium 5 ?µg/Day Delivered Via the Respimat?® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II) | Активный, набор окончен |
|
| Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis | Активный, набор окончен |
|
| First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | Активный, набор окончен |
|
| Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | Активный, набор окончен |
|
| Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma | Активный, набор окончен |
|
| Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma | Активный, набор окончен |
|
| PREGNANT Short Cervix Trial | Активный, набор окончен |
|
| Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease | Активный, набор окончен |
|
| Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 | Активный, набор окончен |
|
| A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies | Активный, набор окончен |
|
| Safety and Efficacy of BI 1356 as Monotherapy or in Combination in Type 2 DM | Активный, набор окончен |
|
| Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer | Активный, набор окончен |
|
| Oral Cladribine in Early Multiple Sclerosis (MS) | Активный, набор окончен |
|
| Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease | Активный, набор окончен |
|
| Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma | Активный, набор окончен |
|
| A Phase III A Study to Assess the Safety of CDP870 for up to 84 Months Exposure | Активный, набор окончен |
|
| Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer | Активный, набор окончен |
|
| Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in theTreatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen | Активный, набор окончен |
|
| A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) | Активный, набор окончен |
|
| Study of Picoplatin Efficacy After Relapse | Активный, набор окончен |
|
| BI 10773 in Type Two Diabetes (T2D) Patients, Open Label Extension | Активный, набор окончен |
|
| A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma | Активный, набор окончен |
|
| Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis | Активный, набор окончен |
|
| A Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | Активный, набор окончен |
|
| A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma | Активный, набор окончен |
|
| A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate | Активный, набор окончен |
|
| A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) | Активный, набор окончен |
|
| Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis | Активный, набор окончен |
|
| A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | Активный, набор окончен |
|
| Lucrin?® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) | Активный, набор окончен |
|
| A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes | Активный, набор окончен |
|
| Evaluation of Tiotropium 5 ?µg/Day Delivered Via the Respimat?® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I) | Активный, набор окончен |
|
| Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo | Активный, набор окончен |
|
| A Trial of Degarelix in Patients With Prostate Cancer | Активный, набор окончен |
|
| GLP-1 Agonist AVE0010 (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | Активный, набор окончен |
|
| Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial | Активный, набор окончен |
|
| BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | Активный, набор окончен |
|
| 24-week Study Comparing Lixisenatide (AVE0010) to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 | Активный, набор окончен |
|
| A Phase III Study of Apixaban in Patients With Atrial Fibrillation | Активный, набор окончен |
|
| A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML) | Активный, набор окончен |
|
